CAR-T therapy is a relatively new immunotherapy treatment for advanced B-cell lymphomas, including non-Hodgkin’s lymphoma (NHL). It is usually reserved for patients who have had more than one previous line of treatment but relapsed anyway. The standard course of treatment for non-Hodgkin’s lymphoma is chemotherapy, which cures about 70% of...
Read MoreShould CAR-T be used earlier for NHL patients?
